A decision aid tool will be modified and piloted specifically to support and inform shared decision making for older adults with low health literacy considering colorectal cancer screening.
We apply the latest science to create, test, and scale solutions to address the most intractable problems in cancer care delivery.
We are change agents dedicated to designing, testing, scaling and disseminating innovations in cancer care.
Through value-based care analyses and focus groups, this study seeks to assess value, safety, and feasibility of telehealth in clinical trials for patients with gynecologic malignancies.
Fifty percent of gynecologic oncology patients experience financial toxicity. This intervention introduces a financial navigation program to mitigate financial toxicity and provide support for patients during treatment.
This program seeks to reduce the financial impact of multiple myeloma on patients and their families by providing coordinated financial navigation.
The Penn Implementation Science Center in Cancer Control (ISC3) is a $4.9 million, five-year grant from the National Cancer Institute whose goal is to apply insights from behavioral economics to rapidly accelerate the pace at which evidence-based practices for cancer care are deployed and the extent to which they are delivered equitably, thereby increasing their reach and impact on the health and health equity of individuals with cancer.